SCHEMBL2923213

SCHEMBL2923213

Oc1c(F)c(F)c(F)c(F)c1F.[LiH]

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28140273 0.95 ESR1 (0.31) ESR1
SCHEMBL34203 0.95 ESR1 (0.31) ESR1
SCHEMBL3706878 0.91 ESR1 (0.30) ESR1
SCHEMBL2121680 0.91 ESR1 (0.30) ESR1
Water SCHEMBL16552982 0.91 ESR1 (0.30) ESR1
SCHEMBL1960784 0.91 ESR1 (0.30) ESR1
SCHEMBL390508 0.91 ESR1 (0.30) ESR1
SCHEMBL1960786 0.91 ESR1 (0.30) ESR1
Tetrafluororesorcinol SCHEMBL123852 0.91 ESR1 (0.30) ESR1
SCHEMBL18729668 0.91 ESR1 (0.30) ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074549-B Olefin polymerization activator 陶氏环球技术有限责任公司 2023-06-23 CN disclosed
US-11447584-B2 Olefin polymerization activators DOW GLOBAL TECHNOLOGIES LLC (US) 2022-09-20 US disclosed
US-20210054119-A1 OLEFIN POLYMERIZATION ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2021-02-25 US disclosed
EP-3774942-A1 OLEFIN POLYMERIZATION ACTIVATORS Dow Global Technologies LLC (US) 2021-02-17 EP disclosed
CN-112074549-A Olefin polymerization activator 陶氏环球技术有限责任公司 2020-12-11 CN disclosed
WO-2019191098-A1 OLEFIN POLYMERIZATION ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-10-03 WO disclosed
EP-2232612-B1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS GLOBAL OLED TECHNOLOGY LLC (US) 2017-02-08 EP disclosed
US-8900722-B2 OLED device employing alkali metal cluster compounds GLOBAL OLED TECHNOLOGY LLC (US) 2014-12-02 US disclosed
CN-101878554-B Oled device employing alkali metal cluster compounds GLOBAL OLED TECHNOLOGY LLC 2012-07-25 CN disclosed
CN-101878554-A Oled device employing alkali metal cluster compounds EASTMAN KODAK CO 2010-11-03 CN disclosed
EP-2232612-A1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS Global OLED Technology LLC (US) 2010-09-29 EP disclosed
WO-2009073088-A1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS EASTMAN KODAK COMPANY (US) 2009-06-11 WO disclosed
US-20090142618-A1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS GLOBAL OLED TECHNOLOGY LLC 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090142618-A1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS OCIAD2, OCIAD1, OSTC ESR1 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.